# U S Physical Therapy Inc: filings

USPH · NYSE · CIK 885978 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/usph.md) · [Financials](/companies/usph/financials.md) · [Filings](/companies/usph/filings.md) · [Insiders](/companies/usph/insiders.md)

## Reports and events: 520 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 543, 8-K 425, SC 13G/A 61, 10-Q 53, 144 43, 10-K 18, DEF 14A 18, SC 13G 18, CORRESP 15, 3 14, UPLOAD 14, SCHEDULE 13G/A 10, 4/A 9, SCHEDULE 13G 9, ARS 4, S-8 4, 8-K/A 3, DEFA14A 3, 10-K/A 2, 424B5 2, 8-A12B 2, NT 10-Q 2, 10-Q/A 1, 25 1, 3/A 1, 5 1, CERT 1, CERTNYS 1, NT 10-K 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 17:08 ET | [8-K](/filings/0000885978-26-000060.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000885978-26-000060 |
| 2026-09-21 | 16:17 ET | [8-K](/filings/0000885978-26-000057.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885978-26-000057 |
| 2026-08-14 | 16:17 ET | [8-K](/filings/0000885978-26-000052.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000052 |
| 2026-08-12 | 16:09 ET | [8-K](/filings/0000885978-26-000048.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000048 |
| 2026-08-10 | 16:12 ET | [8-K](/filings/0000885978-26-000045.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000045 |
| 2026-08-07 | 16:08 ET | [10-Q](/filings/0001140361-26-031825.md) | Quarterly report, period 2026-06-30 | 0001140361-26-031825 |
| 2026-08-06 | 16:10 ET | [8-K](/filings/0000885978-26-000042.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000042 |
| 2026-07-06 | 16:22 ET | [8-K](/filings/0000885978-26-000039.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000039 |
| 2026-05-19 | 16:50 ET | [8-K](/filings/0000885978-26-000027.md) | 5.07 Shareholder vote results | 0000885978-26-000027 |
| 2026-05-11 | 17:12 ET | [8-K](/filings/0000885978-26-000024.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000024 |
| 2026-05-08 | 16:06 ET | [10-Q](/filings/0001140361-26-020025.md) | Quarterly report, period 2026-03-31 | 0001140361-26-020025 |
| 2026-05-06 | 16:30 ET | [8-K](/filings/0000885978-26-000019.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000019 |
| 2026-04-16 | 06:24 ET | [DEF 14A](/filings/0001140361-26-014952.md) | Proxy statement, period 2026-05-19 | 0001140361-26-014952 |
| 2026-04-15 | 16:19 ET | [8-K](/filings/0000885978-26-000017.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000885978-26-000017 |
| 2026-03-13 | 16:07 ET | [8-K](/filings/0000885978-26-000014.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885978-26-000014 |
| 2026-03-09 | 16:13 ET | [8-K](/filings/0000885978-26-000011.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000011 |
| 2026-03-03 | 16:28 ET | [8-K](/filings/0000885978-26-000009.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000009 |
| 2026-02-27 | 17:09 ET | [10-K](/filings/0001140361-26-007170.md) | Annual report, period 2025-12-31 | 0001140361-26-007170 |
| 2026-02-26 | 08:30 ET | [8-K](/filings/0001140361-26-006882.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006882 |
| 2026-02-04 | 16:08 ET | [8-K](/filings/0000885978-26-000006.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000006 |
| 2026-01-07 | 16:05 ET | [8-K](/filings/0000885978-26-000003.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000003 |
| 2025-11-18 | 16:09 ET | [8-K](/filings/0000885978-25-000058.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000058 |
| 2025-11-12 | 16:09 ET | [8-K](/filings/0000885978-25-000056.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000056 |
| 2025-11-07 | 16:05 ET | [10-Q](/filings/0001140361-25-041152.md) | Quarterly report, period 2025-09-30 | 0001140361-25-041152 |
| 2025-11-06 | 16:22 ET | [8-K](/filings/0000885978-25-000053.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000053 |
| 2025-08-12 | 16:10 ET | [8-K](/filings/0000885978-25-000046.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000046 |
| 2025-08-11 | 16:25 ET | [8-K](/filings/0000885978-25-000044.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000044 |
| 2025-08-08 | 08:22 ET | [10-Q](/filings/0001140361-25-029744.md) | Quarterly report, period 2025-06-30 | 0001140361-25-029744 |
| 2025-08-07 | 07:33 ET | [8-K](/filings/0000885978-25-000041.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000041 |
| 2025-08-01 | 16:12 ET | [8-K](/filings/0000885978-25-000037.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000037 |
| 2025-07-01 | 17:29 ET | [8-K](/filings/0000885978-25-000032.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000032 |
| 2025-05-28 | 16:26 ET | [8-K](/filings/0000885978-25-000019.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000019 |
| 2025-05-20 | 16:43 ET | [8-K](/filings/0000885978-25-000017.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000885978-25-000017 |
| 2025-05-13 | 16:16 ET | [8-K](/filings/0000885978-25-000014.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000014 |
| 2025-05-13 | 17:42 ET | [8-K](/filings/0000885978-25-000012.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000012 |
| 2025-05-09 | 16:05 ET | [10-Q](/filings/0001140361-25-018157.md) | Quarterly report, period 2025-03-31 | 0001140361-25-018157 |
| 2025-05-07 | 17:01 ET | [8-K](/filings/0000885978-25-000010.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000010 |
| 2025-04-30 | 16:11 ET | [8-K](/filings/0000885978-25-000008.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000008 |
| 2025-04-11 | 16:03 ET | [DEF 14A](/filings/0001140361-25-013467.md) | Proxy statement, period 2025-05-20 | 0001140361-25-013467 |
| 2025-03-28 | 06:02 ET | [8-K](/filings/0001140361-25-010807.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-010807 |
| 2025-03-07 | 08:57 ET | [8-K](/filings/0000885978-25-000006.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000006 |
| 2025-03-03 | 16:15 ET | [10-K](/filings/0001140361-25-006750.md) | Annual report, period 2024-12-31 | 0001140361-25-006750 |
| 2025-03-03 | 14:32 ET | [8-K](/filings/0000885978-25-000004.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000004 |
| 2025-02-27 | 17:15 ET | [8-K](/filings/0000885978-25-000002.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000002 |
| 2024-12-02 | 16:07 ET | [8-K](/filings/0000885978-24-000068.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000068 |
| 2024-11-12 | 16:07 ET | [8-K](/filings/0000885978-24-000066.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000066 |
| 2024-11-08 | 16:24 ET | [8-K](/filings/0000885978-24-000064.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000064 |
| 2024-11-08 | 16:01 ET | [10-Q](/filings/0001140361-24-045836.md) | Quarterly report, period 2024-09-30 | 0001140361-24-045836 |
| 2024-11-06 | 16:05 ET | [8-K](/filings/0000885978-24-000062.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000062 |
| 2024-11-01 | 16:05 ET | [8-K](/filings/0000885978-24-000059.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events | 0000885978-24-000059 |

Page 1 of 11. [Older](/companies/usph/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:40 ET. No prices; not investment advice.